carbapenems has been researched along with erythromycin in 3 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (erythromycin) | Trials (erythromycin) | Recent Studies (post-2010) (erythromycin) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 14,524 | 1,138 | 1,926 |
Protein | Taxonomy | carbapenems (IC50) | erythromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 1.156 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.045 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 1.156 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 1.156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Ferreira, TP; Gobbi, DD; Hofer, E; Matté, GR; Matté, MH; Moreno, AM; Moreno, LZ; Paixão, R; Raimundo, DC; Reis, CM | 1 |
Hirai, J; Koizumi, Y; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Sugimoto, N; Yamagishi, Y | 1 |
1 review(s) available for carbapenems and erythromycin
Article | Year |
---|---|
Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Erythromycin; Hospitalization; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Serogroup; Serotyping; Streptococcus pneumoniae; Treatment Outcome | 2017 |
2 other study(ies) available for carbapenems and erythromycin
Article | Year |
---|---|
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections.
Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Clindamycin; Daptomycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Humans; Listeria; Microbial Sensitivity Tests; Oxacillin; Swine; Tetracycline | 2014 |